Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Japanese Encephalitis Vaccines | 3 | 2019 | 14 | 2.18 | Why? |
| Encephalitis, Japanese | 3 | 2019 | 58 | 2.04 | Why? |
| Encephalitis Virus, Japanese | 3 | 2019 | 63 | 1.60 | Why? |
| Dysentery, Amebic | 1 | 2018 | 6 | 0.77 | Why? |
| Entamoebiasis | 1 | 2018 | 10 | 0.77 | Why? |
| AIDS-Related Opportunistic Infections | 1 | 2018 | 260 | 0.60 | Why? |
| Colectomy | 1 | 2018 | 327 | 0.57 | Why? |
| Endemic Diseases | 1 | 2017 | 480 | 0.51 | Why? |
| Travel-Related Illness | 1 | 2017 | 1357 | 0.40 | Why? |
| Immunization Programs | 1 | 2019 | 2006 | 0.31 | Why? |
| Immunity, Cellular | 1 | 2017 | 3614 | 0.26 | Why? |
| T-Lymphocytes | 2 | 2021 | 6670 | 0.26 | Why? |
| Viral Plaque Assay | 2 | 2020 | 381 | 0.21 | Why? |
| Hemagglutination Tests | 1 | 2021 | 124 | 0.21 | Why? |
| Dengue Virus | 2 | 2019 | 910 | 0.21 | Why? |
| Cross Reactions | 3 | 2021 | 4374 | 0.19 | Why? |
| Entamoeba histolytica | 1 | 2018 | 22 | 0.19 | Why? |
| Amebicides | 1 | 2018 | 22 | 0.18 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.18 | Why? |
| Blood Specimen Collection | 1 | 2021 | 387 | 0.16 | Why? |
| Respiration, Artificial | 3 | 2021 | 22116 | 0.16 | Why? |
| Clinical Deterioration | 1 | 2021 | 473 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| United Kingdom | 12 | 2021 | 18046 | 0.16 | Why? |
| Vaccination | 2 | 2017 | 19050 | 0.14 | Why? |
| HIV | 2 | 2021 | 1116 | 0.14 | Why? |
| Antibodies, Neutralizing | 2 | 2019 | 25288 | 0.14 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.14 | Why? |
| Nepal | 1 | 2019 | 1004 | 0.14 | Why? |
| Central Nervous System | 1 | 2020 | 701 | 0.14 | Why? |
| Immunologic Memory | 3 | 2021 | 3362 | 0.14 | Why? |
| Clinical Protocols | 2 | 2021 | 2734 | 0.12 | Why? |
| Colon | 1 | 2018 | 669 | 0.12 | Why? |
| Enzyme-Linked Immunosorbent Assay | 4 | 2021 | 7868 | 0.12 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.11 | Why? |
| Vaccines, Attenuated | 1 | 2017 | 952 | 0.11 | Why? |
| Virus Inactivation | 1 | 2020 | 1139 | 0.11 | Why? |
| Interferon-gamma | 2 | 2021 | 2711 | 0.11 | Why? |
| Asia | 1 | 2017 | 2399 | 0.10 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.10 | Why? |
| Cross Infection | 2 | 2021 | 8675 | 0.09 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2021 | 4545 | 0.09 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.09 | Why? |
| Blood Coagulation Disorders | 1 | 2021 | 2040 | 0.09 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.08 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.08 | Why? |
| Hematologic Neoplasms | 1 | 2021 | 2105 | 0.08 | Why? |
| Clinical Decision-Making | 1 | 2021 | 3755 | 0.08 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2021 | 5837 | 0.08 | Why? |
| New York City | 1 | 2020 | 7432 | 0.08 | Why? |
| Humans | 25 | 2021 | 930598 | 0.07 | Why? |
| Neutralization Tests | 1 | 2019 | 6698 | 0.07 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.07 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.07 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.07 | Why? |
| Dengue | 1 | 2017 | 1565 | 0.07 | Why? |
| World Health Organization | 3 | 2021 | 4213 | 0.07 | Why? |
| Observational Studies as Topic | 2 | 2021 | 1887 | 0.06 | Why? |
| Decision Making | 1 | 2017 | 3132 | 0.06 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.06 | Why? |
| Seroepidemiologic Studies | 1 | 2019 | 10017 | 0.06 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.06 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.06 | Why? |
| Male | 11 | 2021 | 367725 | 0.06 | Why? |
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2020 | 73 | 0.06 | Why? |
| Chromosomes, Human, Pair 19 | 1 | 2020 | 77 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2019 | 9091 | 0.06 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.06 | Why? |
| Chromosomes, Human, Pair 12 | 1 | 2020 | 84 | 0.05 | Why? |
| Chromosomes, Human, Pair 21 | 1 | 2020 | 90 | 0.05 | Why? |
| TYK2 Kinase | 1 | 2020 | 116 | 0.05 | Why? |
| Receptors, CCR2 | 1 | 2020 | 103 | 0.05 | Why? |
| Agglutination Tests | 1 | 2021 | 124 | 0.05 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.05 | Why? |
| Formaldehyde | 1 | 2020 | 135 | 0.05 | Why? |
| Detergents | 1 | 2020 | 107 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 6653 | 0.05 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.05 | Why? |
| 2',5'-Oligoadenylate Synthetase | 1 | 2020 | 205 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.05 | Why? |
| Multigene Family | 1 | 2020 | 377 | 0.05 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.05 | Why? |
| Female | 11 | 2021 | 380317 | 0.05 | Why? |
| India | 1 | 2017 | 11875 | 0.05 | Why? |
| Sequence Analysis | 1 | 2020 | 496 | 0.05 | Why? |
| Methanol | 1 | 2020 | 149 | 0.05 | Why? |
| Histones | 1 | 2021 | 371 | 0.05 | Why? |
| Phenols | 1 | 2020 | 226 | 0.05 | Why? |
| DNA, Complementary | 1 | 2020 | 568 | 0.05 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2020 | 610 | 0.05 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.05 | Why? |
| Ghana | 1 | 2021 | 763 | 0.04 | Why? |
| HEK293 Cells | 2 | 2021 | 8394 | 0.04 | Why? |
| Biological Assay | 1 | 2020 | 367 | 0.04 | Why? |
| Dried Blood Spot Testing | 1 | 2021 | 383 | 0.04 | Why? |
| Adult | 6 | 2021 | 244371 | 0.04 | Why? |
| Norway | 1 | 2021 | 1004 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Russia | 1 | 2021 | 989 | 0.04 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Colombia | 1 | 2021 | 1241 | 0.04 | Why? |
| Guanidines | 1 | 2020 | 499 | 0.04 | Why? |
| Polymers | 1 | 2020 | 507 | 0.04 | Why? |
| HIV Infections | 1 | 2021 | 11620 | 0.04 | Why? |
| Immunodominant Epitopes | 1 | 2020 | 813 | 0.04 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.04 | Why? |
| Molecular Epidemiology | 1 | 2020 | 1638 | 0.03 | Why? |
| Lung | 2 | 2020 | 31049 | 0.03 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.03 | Why? |
| Cell Proliferation | 1 | 2021 | 1973 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2020 | 1648 | 0.03 | Why? |
| Coronavirus OC43, Human | 1 | 2021 | 1157 | 0.03 | Why? |
| Aged | 5 | 2021 | 215776 | 0.03 | Why? |
| Coronavirus 229E, Human | 1 | 2021 | 1241 | 0.03 | Why? |
| Respiratory Tract Diseases | 1 | 2021 | 1061 | 0.03 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.03 | Why? |
| Critical Care | 3 | 2021 | 14081 | 0.03 | Why? |
| Hot Temperature | 1 | 2020 | 1299 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 1439 | 0.03 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.03 | Why? |
| Animals | 2 | 2020 | 78931 | 0.03 | Why? |
| Ultraviolet Rays | 1 | 2020 | 1272 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| South Africa | 1 | 2021 | 3326 | 0.03 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.03 | Why? |
| DNA, Viral | 1 | 2020 | 2521 | 0.03 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2020 | 2262 | 0.02 | Why? |
| Peptides | 1 | 2021 | 2513 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3633 | 0.02 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.02 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.02 | Why? |
| State Medicine | 1 | 2021 | 2847 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2021 | 2984 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.02 | Why? |
| Research Design | 1 | 2021 | 5830 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Nervous System Diseases | 1 | 2021 | 4092 | 0.01 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.01 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| Italy | 1 | 2021 | 38444 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2021 | 11497 | 0.01 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
Turtle's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(171)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(506)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_